These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 18822183)

  • 21. Growth suppression of HER2-overexpressing breast cancer cells by berberine via modulation of the HER2/PI3K/Akt signaling pathway.
    Kuo HP; Chuang TC; Yeh MH; Hsu SC; Way TD; Chen PY; Wang SS; Chang YH; Kao MC; Liu JY
    J Agric Food Chem; 2011 Aug; 59(15):8216-24. PubMed ID: 21699261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options.
    Scartozzi M; Bearzi I; Berardi R; Mandolesi A; Pierantoni C; Cascinu S
    Br J Cancer; 2007 Jul; 97(1):92-7. PubMed ID: 17579627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogene alterations in endometrial carcinosarcomas.
    Biscuola M; Van de Vijver K; Castilla MÁ; Romero-Pérez L; López-García MÁ; Díaz-Martín J; Matias-Guiu X; Oliva E; Palacios Calvo J
    Hum Pathol; 2013 May; 44(5):852-9. PubMed ID: 23199529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro.
    Wang TF; Wang H; Peng AF; Luo QF; Liu ZL; Zhou RP; Gao S; Zhou Y; Chen WZ
    Biochem Biophys Res Commun; 2013 Oct; 440(2):229-34. PubMed ID: 24041695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability.
    Mellinghoff IK; Vivanco I; Kwon A; Tran C; Wongvipat J; Sawyers CL
    Cancer Cell; 2004 Nov; 6(5):517-27. PubMed ID: 15542435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients.
    Payne RE; Yagüe E; Slade MJ; Apostolopoulos C; Jiao LR; Ward B; Coombes RC; Stebbing J
    Pharmacogenomics; 2009 Jan; 10(1):51-7. PubMed ID: 19102715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perioperative serum VEGF and extracellular domains of EGFR and HER2 in early breast cancer.
    Rocca A; Cancello G; Bagnardi V; Sandri MT; Torrisi R; Zorzino L; Viale G; Pietri E; Veronesi P; Dellapasqua S; Ferrucci F; Luini A; Johansson H; Ghisini R; Goldhirsch A; Colleoni M
    Anticancer Res; 2009 Dec; 29(12):5111-9. PubMed ID: 20044624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor.
    Tan AR; Yang X; Hewitt SM; Berman A; Lepper ER; Sparreboom A; Parr AL; Figg WD; Chow C; Steinberg SM; Bacharach SL; Whatley M; Carrasquillo JA; Brahim JS; Ettenberg SA; Lipkowitz S; Swain SM
    J Clin Oncol; 2004 Aug; 22(15):3080-90. PubMed ID: 15284258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes.
    Xue G; Restuccia DF; Lan Q; Hynx D; Dirnhofer S; Hess D; Rüegg C; Hemmings BA
    Cancer Discov; 2012 Mar; 2(3):248-59. PubMed ID: 22585995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
    Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas.
    Chakravarti A; Zhai G; Suzuki Y; Sarkesh S; Black PM; Muzikansky A; Loeffler JS
    J Clin Oncol; 2004 May; 22(10):1926-33. PubMed ID: 15143086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib.
    Kalykaki A; Agelaki S; Kallergi G; Xyrafas A; Mavroudis D; Georgoulias V
    Cancer Chemother Pharmacol; 2014 Apr; 73(4):685-93. PubMed ID: 24493157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients.
    Kallergi G; Agelaki S; Papadaki MA; Nasias D; Matikas A; Mavroudis D; Georgoulias V
    Breast Cancer Res; 2015 Aug; 17(1):113. PubMed ID: 26285572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-kappaB signalling pathway and prognostic significance in prostate cancer.
    Koumakpayi IH; Le Page C; Mes-Masson AM; Saad F
    Br J Cancer; 2010 Mar; 102(7):1163-73. PubMed ID: 20216540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of epidermal growth factor receptor signaling pathway by delphinidin, an anthocyanidin in pigmented fruits and vegetables.
    Afaq F; Zaman N; Khan N; Syed DN; Sarfaraz S; Zaid MA; Mukhtar H
    Int J Cancer; 2008 Oct; 123(7):1508-15. PubMed ID: 18623129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ganglioside GM3 inhibits hepatoma cell motility via down-regulating activity of EGFR and PI3K/AKT signaling pathway.
    Huang X; Li Y; Zhang J; Xu Y; Tian Y; Ma K
    J Cell Biochem; 2013 Jul; 114(7):1616-24. PubMed ID: 23355442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HER2+ Cancer Cell Dependence on PI3K vs. MAPK Signaling Axes Is Determined by Expression of EGFR, ERBB3 and CDKN1B.
    Kirouac DC; Du J; Lahdenranta J; Onsum MD; Nielsen UB; Schoeberl B; McDonagh CF
    PLoS Comput Biol; 2016 Apr; 12(4):e1004827. PubMed ID: 27035903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct regulatory effect of the p34SEI-1 oncoprotein on cancer metastasis in HER2/neu-positive and -negative cells.
    Jung S; Ohk J; Jeong D; Li C; Lee S; Duan J; Kim C; Lim JS; Yang Y; Kim KI; Lee MS
    Int J Oncol; 2014 Jul; 45(1):189-96. PubMed ID: 24789658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Akt kinase-interacting protein 1, a scaffold protein of the PI3K/PDK1/Akt pathway, in pancreatic cancer.
    Ohtsubo K; Yamada T; Zhao L; Jin TF; Takeuchi S; Mouri H; Yamashita K; Yasumoto K; Fujita N; Kitagawa H; Ohta T; Ikeda H; Yano S
    Pancreas; 2014 Oct; 43(7):1093-100. PubMed ID: 25036909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
    Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
    Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.